InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,377.26
(
0.21%
)

Replies to post #380660 on Elite Pharmaceuticals Inc (ELTP)

Replies to #380660 on Elite Pharmaceuticals Inc (ELTP)

jour_trader

06/03/23 9:24 AM

#380661 RE: sharkey1 #380660

Purdue has been able to file new patents for OxyContin 13 times with the US Patent and Trademark Office over the past decade, thereby extending its exclusive selling rights on the drug through 2030.